MEDEZE 株価分析 — Medeze Group Public Company Limited (Healthcare >> Medical Care Facilities)
MEDEZE に関するよくある質問
MEDEZEのPER(株価収益率)は?
Medeze Group Public Company Limited(MEDEZE)は現在PER 44.12倍で取引されています。
MEDEZEのROE(自己資本利益率)は?
Medeze Group Public Company LimitedのROEは5.24%です。
MEDEZEの配当利回りは?
Medeze Group Public Company Limitedの配当利回りは2.48%です。
MEDEZEの品質スコア(Quality Score)は?
当社のAIはMEDEZEの総合財務品質を100点中54点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
MEDEZEは今が買い時ですか?
当社AIのタイミングスコアは100点中71点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
MEDEZEはどのセクターに属しますか?
Medeze Group Public Company LimitedはHealthcare >> Medical Care Facilitiesセクターに分類されます(SET市場)
MEDEZE AI Analysis Summary
Our AI summary for MEDEZE: Medeze Group Public Company Limited (SET), Healthcare >> Medical Care Facilities sector. The stock currently trades at a P/E of 44.12, ROE of 5.24%, a dividend yield of 2.48%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 71/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
THB 6.55
Price
0.10
(1.55%)
Day Change
|
|
|---|
MEDEZE, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) but テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.09 From 30 days period |
| Watch Rate | 0.08 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
488
|
| Magic Formula Rank by ROE |
488
|
| Magic Formula Rank by ROIC |
499
|
| Price | 6.55 |
| PBV / Sector |
2.31 / 1.51
|
| Earning Per Share | 0.15 |
| PE / Sector |
44.12 / 20.84
|
| PEG or PE/Growth / Sector |
N/A / -0.91
|
| Average 1M Daily Value |
3.30 M
GREAT
|
| Average 1W Daily Value |
1.41 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
68% |
| 配当 |
|
12% |
| 登録情報 |
| Analyze Date | 2026-08-01 05:27:14 |
| Symbol | MEDEZE |
| Name | MEDEZE GROUP PUBLIC COMPANY LIMITED |
| Sector | Healthcare >> Medical Care Facilities |
| Market | SET |
| Listed Shares | 1,068.00 M |
| Par Value | 1.00 |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.Baht) / Sector Average | 6,888.60 / 21,214.78 |
| ニュース |
| Estimation Consensus | See at SetTrade.com |
| Full details | See at SET.or.th |
| Chart | See in Chart feature |
| News | See at RYT9.com |
Address: 28/9 Moo 8, Nakhon Pathom, Thailand, 73220
Phone: 66 9 1599 9999
Website: https://www.medezegroup.com
Description: Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, Philippines, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells. In addition, the company is involved in research, develops, and collects data on all types of human cellular activities and medical laboratory tests. Further, the company sells dietary supplements, cosmetics, and dermo cosmetics. Medeze Group Public Company Limited was founded in 2010 and is based in Nakhon Pathom, Thailand.
ME vs SECTOR Healthcare >> Medical Care Facilities
Click a bubble to view stock details · Bubble size represents market capitalization share
Google